ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $213,710 | -62.1% | 5,993 | -56.9% | 0.01% | -68.8% |
| Q4 2022 | $563,378 | -30.7% | 13,890 | -43.5% | 0.02% | -33.3% |
| Q3 2022 | $813,000 | -6.4% | 24,596 | -0.4% | 0.02% | -14.3% |
| Q2 2022 | $869,000 | +53.3% | 24,687 | +100.3% | 0.03% | +55.6% |
| Q1 2022 | $567,000 | -31.1% | 12,322 | -0.7% | 0.02% | -33.3% |
| Q4 2021 | $823,000 | +6.2% | 12,411 | 0.0% | 0.03% | -12.9% |
| Q3 2021 | $775,000 | -24.7% | 12,411 | -0.1% | 0.03% | -29.5% |
| Q2 2021 | $1,029,000 | +24.9% | 12,426 | 0.0% | 0.04% | +18.9% |
| Q1 2021 | $824,000 | -40.1% | 12,426 | -30.6% | 0.04% | -17.8% |
| Q4 2020 | $1,375,000 | +5.4% | 17,915 | -40.9% | 0.04% | +7.1% |
| Q3 2020 | $1,305,000 | -51.2% | 30,317 | -51.0% | 0.04% | -47.5% |
| Q2 2020 | $2,673,000 | -13.6% | 61,897 | -42.4% | 0.08% | -7.0% |
| Q1 2020 | $3,093,000 | -64.8% | 107,524 | -22.4% | 0.09% | -46.6% |
| Q4 2019 | $8,786,000 | +16.2% | 138,511 | -48.4% | 0.16% | +20.1% |
| Q3 2019 | $7,562,000 | +210.0% | 268,348 | +191.6% | 0.13% | +243.6% |
| Q2 2019 | $2,439,000 | +256.1% | 92,031 | +146.7% | 0.04% | +290.0% |
| Q1 2019 | $685,000 | – | 37,303 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |